Neurodermatitis
RecruitingICP-332 for Adults with Prurigo Nodularis
ICP-332 for Adults with Prurigo Nodularis
- Disease:Neurodermatitis
- Substances:–
Poland- Participants:18–64 years · 65+ years
Rare diseases
Investigational molecules
Locations
Ul. Prezydenta Ryszarda Kaczorowskiego 7/u 50, 15-375 Bialystok, Poland
Specderm Poznanska Sp. j. in Bialystok, Poland specialises in clinical trials of conditions such as Psoriasis, Acne, Type 2 diabetes mellitus, Arteriosclerosis, and other specialisations. This site conducts important research.
The medical center is at the forefront of dermatology research, focusing on innovative treatments for skin conditions such as plaque psoriasis and chronic hand eczema. Through rigorous clinical trials, the center evaluates the efficacy and safety of novel therapeutic agents, contributing significantly to the understanding and management of these conditions.
By exploring new treatment modalities, the center aims to improve patient outcomes and quality of life for those affected by challenging dermatological disorders.
Specializing in endocrinology, the medical center conducts advanced research on Type 2 Diabetes. The focus is on comparing the effectiveness of emerging treatments to existing standards, thereby enhancing therapeutic strategies for better glycemic control in patients.
Through these studies, the center plays a pivotal role in developing more effective and patient-friendly diabetes management options.
The center is actively involved in the study of infectious diseases, with a particular emphasis on recurrent herpes labialis. By comparing different antiviral formulations, the research aims to optimize treatment protocols and improve patient care.
This research contributes to the development of more effective treatments, reducing the frequency and severity of outbreaks.
In the realm of cosmetic dermatology, the center is pioneering research on acne vulgaris. By testing new topical formulations, the center seeks to enhance the safety and efficacy of acne treatments, offering long-term solutions for patients.
These efforts are crucial in providing effective, sustainable treatment options for individuals struggling with acne.
Clinical trials currently enrolling participants at this site.
ICP-332 for Adults with Prurigo Nodularis
PolandLong-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis
PolandA Study Testing How Well Bimekizumab Works and How Safe It Is for Adults with Palmoplantar Pustulosis
PolandStudy of deucravacitinib compared to placebo in adolescents aged 12-17 years with moderate to severe plaque psoriasis
PolandStudy comparing aciclovir gel and cream effectiveness in treating recurrent cold sores (herpes labialis)
PolandEffect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)
PolandPhase III randomized trial of elecoglipron to assess safety and weight loss in adults with obesity or overweight, with or without type 2 diabetes
PolandA study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease
PolandStudy on the Effectiveness of JNJ-77242113 and Deucravacitinib for Treating Moderate to Severe Plaque Psoriasis in Adults
PolandStudy of LY3454738 for Treating Moderate-to-Severe Atopic Dermatitis in Adults
Poland
PolandEvaluation of CIT-013 at two dose levels compared to placebo for treating moderate to severe Hidradenitis Suppurativa
PolandGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.